{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:54:13Z","timestamp":1794020053820,"version":"4.8.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2022,5,1]]},"DOI":"10.1001\/jamaneurol.2022.0489","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T15:03:29Z","timestamp":1649084609000},"page":"518","source":"Crossref","is-referenced-by-count":124,"title":["Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody\u2013Associated Disease"],"prefix":"10.1001","volume":"79","author":[{"given":"John J.","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Huda","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Hacohen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Great Ormond Street Hospital for Children, London, United Kingdom"},{"name":"Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University, Baltimore, Maryland"},{"name":"Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Lotan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Neurology, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Wilf-Yarkoni","sequence":"additional","affiliation":[{"name":"Department of Neurology, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Stiebel-Kalish","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel"},{"name":"Felsenstein Research Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Hellmann","sequence":"additional","affiliation":[{"name":"Department of Neurology, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias S.","family":"Sotirchos","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda D.","family":"Henderson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University, Baltimore, Maryland"},{"name":"Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Pittock","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"},{"name":"Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"},{"name":"Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tariq","family":"Bhatti","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Eggenberger","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Jacksonville, Florida"},{"name":"Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida"},{"name":"Department of Neuro-Ophthalmology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Di Nome","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Scottsdale, Arizona"},{"name":"Department of Neurology, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Saiz","sequence":"additional","affiliation":[{"name":"Service of Neurology, Hospital Clinic, University of Barcelona, Barcelona, Spain"},{"name":"Neuroimmunology Program, Institut d\u2019Investigaci\u00f3 Biom\u00e8dica August Pi i Sunyer, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[{"name":"NeuroCure Clinical Research Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Berlin Institute of Health, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Experimental and Clinical Research Center, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"Max Delbrueck Center for Molecular Medicine, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell C.","family":"Dale","sequence":"additional","affiliation":[{"name":"Translational Neuroimmunology Group, Kids Neuroscience Centre, Children\u2019s Hospital at Westmead, Sydney, Australia"},{"name":"Department of Neurology, Children\u2019s Hospital at Westmead, Sydney Medical School and Brain and Mind Centre, Faculty of Medicine and Health, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshini","family":"Ramanathan","sequence":"additional","affiliation":[{"name":"Translational Neuroimmunology Group, Kids Neuroscience Centre, Children\u2019s Hospital at Westmead, Sydney, Australia"},{"name":"Department of Neurology, Concord Hospital, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Camera","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Leite","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron L.","family":"Lam","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Neurology, Programs in Neuroscience and Immunology, University of Colorado School of Medicine, Aurora"},{"name":"Department of Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mariotto","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Hodge","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Audoin","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Marseille, Marseille, France"},{"name":"Aix-Marseille University, Center for Magnetic Resonance in Biology and Medicine, French National Centre for Scientific Research, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Maillart","sequence":"additional","affiliation":[{"name":"Department of Neurology, Pitie-Salpetriere Hospital, Assistance Publique\u2014H\u020fpitaux de Paris, Paris, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Inflammatoires Rares du Cerveau et de la Moelle, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Deschamps","sequence":"additional","affiliation":[{"name":"Lyon Civil Hospices, Department of Neurology, Neurologic and Neurosurgical Hospital Pierre Wertheimer, Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Pique","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Maladies Inflammatoires Rares du Cerveau et de la Moelle, Service de Neurologie, Scl\u00e9rose en Plaques, Pathologies de la My\u00e9line et Neuro-inflammation, H\u020fpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin P.","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"},{"name":"Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"},{"name":"Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Maladies Inflammatoires Rares du Cerveau et de la Moelle, Service de Neurologie, Scl\u00e9rose en Plaques, Pathologies de la My\u00e9line et Neuro-inflammation, H\u020fpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"noi220012r1","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study.","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"issue":"1","key":"noi220012r2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"21","key":"noi220012r3","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study.","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"noi220012r4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"noi220012r5","doi-asserted-by":"publisher","DOI":"10.1177\/1756286418762083","article-title":"Defining distinct features of anti-MOG antibody associated central nervous system demyelination.","volume":"11","author":"Weber","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"noi220012r6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"3","key":"noi220012r7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/WCO.0000000000000446","article-title":"Myelin oligodendrocyte glycoprotein antibodies: how clinically useful are they?","volume":"30","author":"Reindl","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"noi220012r8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome.","volume":"195","author":"Chen","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"noi220012r9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-019-1525-1","article-title":"Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease.","volume":"16","author":"Cobo-Calvo","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"2","key":"noi220012r10","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1212\/WNL.0000000000009758","article-title":"Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.","volume":"95","author":"Chen","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"noi220012r11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses, and outcomes in relapsing MOG antibody-associated demyelination.","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"noi220012r12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol"},{"key":"noi220012r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102251","article-title":"Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients.","volume":"44","author":"Whittam","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"noi220012r14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11940-019-0541-x","article-title":"Treatment approaches for MOG-Ab\u2013associated demyelination in children.","volume":"21","author":"Hacohen","year":"2019","journal-title":"Curr Treat Options Neurol"},{"key":"noi220012r15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.msard.2019.04.021","article-title":"Successful intravenous immunoglobulin treatment in relapsing MOG-antibody-associated disease.","volume":"32","author":"Tsantes","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"noi220012r16","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG\u2013associated disorders.","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol"},{"issue":"11","key":"noi220012r17","doi-asserted-by":"publisher","first-page":"e1250","DOI":"10.1212\/WNL.0000000000007096","article-title":"A multicenter comparison of MOG-IgG cell-based assays.","volume":"92","author":"Waters","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"noi220012r18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jamaneurol.2013.5699","article-title":"Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.","volume":"71","author":"Mealy","year":"2014","journal-title":"JAMA Neurol"},{"issue":"4","key":"noi220012r19","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000572","article-title":"Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?","volume":"6","author":"Stiebel-Kalish","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"noi220012r20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brainres.2017.08.012","article-title":"Time is vision in recurrent optic neuritis.","volume":"1673","author":"Osinga","year":"2017","journal-title":"Brain Res"},{"issue":"2","key":"noi220012r21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3810\/pgm.2013.03.2619","article-title":"Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disorders.","volume":"125","author":"Broyles","year":"2013","journal-title":"Postgrad Med"},{"key":"noi220012r22","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1007\/s10875-010-9400-y","article-title":"Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home.","volume":"30","author":"Lucas","year":"2010","journal-title":"J Clin Immunol"},{"issue":"1","key":"noi220012r23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/jns.12158","article-title":"A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.","volume":"21","author":"Lunn","year":"2016","journal-title":"J Peripher Nerv Syst"},{"issue":"9","key":"noi220012r24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"issue":"10","key":"noi220012r25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/jnnp-2017-315998","article-title":"Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases.","volume":"88","author":"Hyun","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"noi220012r26","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/ene.2013.20.issue-5","article-title":"Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy.","volume":"20","author":"Markvardsen","year":"2013","journal-title":"Eur J Neurol"},{"issue":"1","key":"noi220012r27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","article-title":"Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"17","author":"van Schaik","year":"2018","journal-title":"Lancet Neurol"},{"key":"noi220012r28","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103462","article-title":"Treatment of myelin oligodendrocyte glycoprotein antibody\u2013associated disease with subcutaneous immune globulin.","volume":"57","author":"Sotirchos","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"noi220012r29","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s10875-013-9876-3","article-title":"Bioavailability of IgG administered by the subcutaneous route.","volume":"33","author":"Berger","year":"2013","journal-title":"J Clin Immunol"},{"issue":"3S","key":"noi220012r30","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a review of evidence.","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"noi220012r31","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy.","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2790493\/jamaneurology_chen_2022_oi_220012_1651870400.12231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T15:01:39Z","timestamp":1652108499000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2790493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.0489","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}